I have been looking in vane for anti-pd-1 trials that admit both ocular primary and former yervoy treatment. If pd-1 is so good, why don't they have several trials and sites. This is so frustrating to say the least. Margaret
This is an area of great interest, as you well know. I was told by one of the companies that an ocular melanoma cohort is opening later this year, but don't know about prior Yervoy. I will try to get more information.
Thanks so much for checking on that, Tim. Now if they'd just admit former yervoy and have it in nashville or atlanta that would make me so happy. Margaret
Meet and talk to others about melanoma in our forums:
See also: History of the MPIP Forum
–CURE OM Forum
Or, visit the MRF Chat Room!
Get updates on melanoma research, education & advocacy
Helpline: (877) 673-6460
1411 K Street, NW Suite 800
Washington, DC 20005
(800) 673-1290 Office
(202) 347-9678 Fax
The Melanoma Research Foundation (MRF) is leading the melanoma community to transform melanoma from one of the deadliest cancers to one of the most treatable through research, education and advocacy.
The Melanoma Research Foundation is a 501(c)(3) non-profit organization.